Paul A Schaffer

US Patent:

20010012515, Aug 9, 2001

Filed:

Jan 9, 2001

Appl. No.:

09/757716

Inventors:

Holly Magna - Niantic CT, US
Paul Schaffer - Groton CT, US
Michael Lawton - Westbrook CT, US
Sue Yocum - Baltic CT, US
Peter Mitchell - Mystic CT, US
Nancy Hutchinson - Old Lyme CT, US
Lynn Murry - Portola Valley CA, US

International Classification:

A61K039/395
A61K038/46
G01N033/573
C12Q001/68
C12N009/14
C07H021/04
C07K016/00
C07K016/40
C12P021/08

US Classification:

424/146100, 424/094600, 435/007400, 435/195000, 435/006000, 530/388260, 530/387300, 536/023200

Abstract:

The invention provides a human nucleotide pyrophosphohydrolase-2 (NTPPH-2) and polynucleotides which identify and encode NTPPH-2. The invention also provides expression vectors, host cells, agonists, antibodies and antagonists. The invention also provides methods for treating disorders associated with expression of NTPPH-2.

US Patent:

61240958, Sep 26, 2000

Filed:

Dec 22, 1997

Appl. No.:

8/996083

Inventors:

Holly Magna - Niantic CT
Paul Schaffer - Groton CT
Michael Lawton - Westbrook CT
Sue Yocum - Baltic CT
Peter Mitchell - Mystic CT
Nancy Hutchinson - Old Lyme CT
Lynn E. Murry - Portola Valley CA

Assignee:

Incyte Pharmaceuticals, Inc. - Palo Alto CA

International Classification:

C12Q 168
C12N 914
C12N 120
C07H 2104

US Classification:

435 6

Abstract:

The invention provides a human nucleotide pyrophosphohydrolase-2 (NTPPH-2) and polynucleotides which identify and encode NTPPH-2. The invention also provides expression vectors, host cells, agonists, antibodies and antagonists. The invention also provides methods for treating disorders associated with expression of NTPPH-2.

US Patent:

62513893, Jun 26, 2001

Filed:

Oct 28, 1999

Appl. No.:

9/429516

Inventors:

Holly Magna - Niantic CT
Paul Schaffer - Groton CT
Michael Lawton - Westbrook CT
Sue Yocum - Baltic CT
Peter Mitchell - Mystic CT
Nancy Hutchinson - Old Lyme CT
Lynn E. Murry - Portola Valley CA

Assignee:

Incyte Genomics, Inc. - Palo Alto CA

International Classification:

A61K 3846
C12N 912
C12Q 142
C07H 2104

US Classification:

424 946

Abstract:

The invention provides a human nucleotide pyrophosphohydrolase-2 (NTPPH-2) and polynucleotides which identify and encode NTPPH-2. The invention also provides expression vectors, host cells, agonists, antibodies and antagonists. The invention also provides methods for treating disorders associated with expression of NTPPH-2.

US Patent:

20200360004, Nov 19, 2020

Filed:

Jul 31, 2020

Appl. No.:

16/945431

Inventors:

- Somerville NJ, US
Jared SCHNEIDER - Livingston NJ, US
Simon COHN - Lebanon NJ, US
Christopher KOKINELIS - Flemington NJ, US
Paul SCHAFFER - Somerville NJ, US

International Classification:

A61B 17/00
A61M 5/24
A61L 24/10

Abstract:

A dispensing device and cartridge for simultaneous delivery and mixing of multiple co-reactive materials, the cartridge having proximal and distal ends, and having an elongated holder body with substantially parallel longitudinal voids. Multiple syringe bodies are disposed parallel within the voids and multiple co-reactive materials are separately disposed in the syringe bodies. The dispensing device also includes a longitudinal housing which is structured and arranged to receive the cartridge and has a malleable spray or mixing tip for accessing difficult to reach locations.